The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Modern medicines series SGLT2 Inhibitors: Webinar 1 - Understanding SGLT2 inhibition

Modern medicines series SGLT2 Inhibitors: Webinar 1 - Understanding SGLT2 inhibition

Publication date: Wednesday, 10 February 2021
Contributor(s): Vinod Patel, Cliff Bailey

Professor Cliff Bailey and Professor Vinod Patel discuss type 2 diabetes and SGLT2 inhibitors in context plus managing glycaemic control and body weight, specifically covering: T2D as a metabolic & cardio-renal disease; Different glucose-lowering therapies; The SGLT2 inhibitor class; Mechanism of SGLT2 inhibition; Glucose control & weight control in RCTs; Real world efficacy evidence; Tolerability & safety profiles; Positioning in treatment algorithms for T2D.

Download the factsheet to this webinar below or watch the on-demand video here:
View the on-demand webinar

And don't forget to complete the CPD programme on our Sister site BJPCN to get your CPD points and download your certificate: 
Go to the CPD programme*

This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant


*Please note that registration is required to complete the CPD module. Simply register to create your free-of-charge personal account
 

Sponsorship information:
This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant
Topics covered:
Category: Webinars
Edition: Volume 1 Number 1 February 2021
Contributor(s): Vinod Patel, Cliff Bailey

Article search and filter